TD Waterhouse Canada’s XBiotech XBIT Stock Holding History

TD Waterhouse Canada’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-200	Closed	-$928	–	1829
2023 Q1	$928	Buy	+200	New	+$745	﹤0.01%	1607

Other funds holding XBIT

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TD Waterhouse Canada's XBIT Position: Q2 2023 in Review

TD Waterhouse Canada sold out of XBiotech (XBIT) in Q2 2023, closing a stake of 200 shares — an estimated $928 sold.

TD Waterhouse Canada first reported a position in XBIT in Q1 2023 and held it in 1 quarter. The position peaked at $928 in Q1 2023. 39 funds tracked by Wall St. Rank hold XBIT as of Q2 2023.

TD Waterhouse Canada reported no remaining XBiotech position as of Q2 2023 after selling out during the quarter.
TD Waterhouse Canada sold 200 XBiotech shares in Q2 2023, an estimated $928.
TD Waterhouse Canada first reported a position in XBiotech in Q1 2023 and held it in 1 quarter.
TD Waterhouse Canada's XBiotech position peaked at $928 in Q1 2023.
39 funds tracked by Wall St. Rank held XBiotech as of Q2 2023.

Based on TD Waterhouse Canada's 13F filing for Q2 2023, filed 13 Nov 2023.